Connect

The new wave of peptide therapy delivery.

A reusable, FDA 510(K)-cleared peptide pen. 3 mL cartridges compounded in PCAB-accredited 503A pharmacies across 45 states. NAD+, BPC‑157, Sermorelin, and a clinically meaningful peptide formulary, dosed in 1 IU clicks and shipped direct to the patient.

We are currently capacity-constrained. Join the waitlist for priority access as new supply opens up.

Join the waitlist General inquiry
503A
Pharmacy network
45
State coverage
510K
FDA cleared device
AXIOM reusable peptide injector pen medical device

Powered by PCAB-accredited 503A pharmacies

HILLSTONE PHARMETIKA BELCHER 503B + EXPANDING

The platform

One audited workflow, every order.

Scripts in, status out. The pipeline view shows every order across every pharmacy, with patient-state routing, real-time dispatch status, and the audit trail one click away.

app.axiomscript.com / admin / pipeline
Order pipeline
Global view across all pharmacies, partners, and clinics.
Pharmacy: All Status: All State: All
Orders today
142
Active partners
3
In production
38
Shipped today
61
OrderClinicPatientProductPharmacyStatus
AXM-49101Coastal WellnessS.T.NAD+ 100mgHillstoneRouted
AXM-49100Game DayJ.D.BPC-157 5mgMills (Pharmetika)Producing
AXM-49099Renew HealthM.K.Sermorelin 9mgBelcher 503BShipped
AXM-49098Coastal WellnessR.P.NAD+ 100mgHillstoneRouted

The new standard

The pen, the cartridge, and the pharmacy network in one regulated program.

Most compounded peptide therapy still relies on multi-dose vials, draw-up syringes, and refill paperwork that doesn’t scale. Adherence drops, errors rise, and the regulator-facing audit trail is fragmented across three or four systems.

AXIOM consolidates the workflow. A 510(K)-cleared reusable pen, 3 mL cartridges compounded in PCAB-accredited 503A pharmacies, dose accuracy down to 0.01 mL per click, and a single audit log that spans script through fulfillment. Each cartridge runs roughly 4–5 weeks of therapy at a typical prescribed dose.

ISO 11608-3 compatible 3 mL glass cartridges for reusable pen injectors

The program

From script to fulfillment in a single audited workflow.

Clinicians write the script in their existing portal. The routing engine selects a PCAB-accredited 503A pharmacy licensed in the patient’s state, applies any pricing tier the corporation has negotiated, and hands off through a HMAC-verified inbound API. Status events flow back, the audit log captures every transition, and Net 7 invoicing closes the loop.

For the clinician

Pick the patient, pick the peptide, pick the dose. Submit. Done. The right pharmacy is selected for the patient’s state. The cartridge ships pre-filled. Status updates flow back automatically. Billing settles cleanly at week’s end.

  • License-state validation per patient
  • Bulk patient upload by CSV
  • Per-user PHI scoping for the front desk

For the pharmacy

Orders land already validated against your license states and your eligible peptide list. Production schedule, lot logs, consumable inventory, SOP photo capture all in one place. The phone stops ringing. The email thread ends.

  • Predictable, level-loaded production
  • Lot traceability for every cartridge shipped
  • Built-in ticketing, no more email

For the network

Bringing AXIOM to a network of clinics, a franchise system, or a telehealth brand? One contract, one settlement, one branded patient experience across every location. Your logo on the pen, your subdomain on the portal, your patients on the program.

  • Custom-branded pen and packaging
  • Roll-up reporting across every location
  • Your subdomain, your colors, your portal
PCAB Pharmacy Compounding Accreditation Board accredited badge

Pharmacy network accreditation

PCAB-accredited pharmacies on every order.

Every fulfillment runs through a PCAB-accredited pharmacy. Accreditation comes only after rigorous, third-party quality and safety inspections by the National Association of Boards of Pharmacy and the Accreditation Commission for Health Care.

  • Cleanliness and sterile processes
  • Proper ingredient sourcing
  • Accurate dosing and formulation
  • Staff training and procedures

The formulary

A cartridge for every protocol.

Each 3 mL cartridge is compounded to the dose strength the prescriber writes, with roughly 4–5 weeks of therapy per cartridge at typical prescribed regimens. The formulary expands quarterly as additional 503A pharmacies onboard new peptides into the AXIOM-validated cartridge fill process.

Available now

NAD+

Cellular energy and longevity support.

CJC‑1295 / Ipamorelin / Sermorelin

Growth-hormone optimization blend.

Pentadeca Arginate

Performance and recovery peptide.

Expanding formulary

Coming Soon

Sermorelin

Growth-hormone-releasing peptide.

Coming Soon

Thymosin Alpha‑1

Immune-system modulator.

Coming Soon

BPC‑157 / TB‑500

Tissue repair and recovery.

Coming Soon

GHK‑Cu / KPV / TB / BPC

Advanced regenerative stack.

Coming Soon

Tesamorelin

Targeted metabolic peptide.

Coming Soon

MOTS‑C

Mitochondrial-derived peptide.

All cartridges are compounded by licensed AXIOM-enabled pharmacies. Product availability may vary by state and regulatory status.

Nationwide availability

45 states of licensed pharmacy coverage. Patient-state routing built in.

AXIOM’s routing engine matches each prescription to a pharmacy holding an active license in the patient’s ship-to state. Cross-state shipping happens through licensed channels only; the order audit log records the routed pharmacy, the state-license id checked, and the timestamp.

45+
States active and growing
3
Live pharmacies
8
Active SKUs
4
Channel modes

Coast to coast. State by state.

Every cartridge ships from a pharmacy licensed in the patient’s state. Fast, compliant, nationwide. New states come online as additional 503A pharmacies join the network.

45 states active today. Patient’s state is matched to a licensed pharmacy automatically. Clinicians never have to check.
5 states pending. Alabama, Arkansas, California, Massachusetts, South Carolina, all expected within the next two quarters.

Contact us to confirm coverage for specific patient ZIP codes before onboarding a new clinic.

Engineered for real clinical use

Engineered for self-administration; documented for the prescriber.

AXIOM peptide therapy is self-administered in the patient’s home, typically daily or weekly. The pen is engineered for that context (1 IU click resolution, sub-8 N actuation force at therapeutic doses, no syringe draw step). The clinician portal mirrors the actual fill records, tracking numbers, and lot data for chart documentation.

Precise dosing, every click

0 to 60 IU per injection. One click equals one IU equals 0.01 mL. No drawing, no guessing, no math at the kitchen table.

3,000 + injection cycles

One pen lasts. Replaceable 3 mL cartridges swap by hand. No tools, no waste, no patient frustration with a new device every month.

FDA 510(K) cleared

Produced in a cGMP, ISO 13485:2016 facility. ISO 11608 compatible needles and cartridges. The device side of the program holds up to scrutiny.

Pre-filled, pharmacy-compounded

Cartridges arrive ready to load. No vials in the kitchen, no syringes in the trash. The patient’s job is to click the dose. The pharmacy’s job is to make sure the cartridge is right.

4 to 5 weeks per cartridge

Calibrated to real prescribing patterns, not arbitrary fill volumes. One cartridge covers a typical month of therapy, then the patient swaps in a fresh one.

An expanding peptide formulary

NAD+, BPC‑157, Sermorelin, Pentadeca Arginate today. Thymosin Alpha‑1, Tesamorelin, MOTS‑C, regenerative stacks queued up next. New peptides come online without changing how the patient uses the pen.

AXIOM reusable peptide injector pen in carrying case

Regulatory posture

FDA 510(K), PCAB, ISO 13485, 21 CFR Part 11.

The pen device is FDA 510(K) cleared (K-number K243857). Cartridges are compounded in PCAB-accredited 503A pharmacies. Manufacture runs in a cGMP, ISO 13485:2016, ISO 9001 certified facility. The audit log retention is seven years per 21 CFR Part 11.10(e), with append-only storage on the application database and an S3 Object Lock sidecar for immutable off-platform retention.

FDA 510(K) Cleared
ISO 11608-1 Compliant
cGMP / ISO 13485:2016
HIPAA + 21 CFR Part 11

White-label

Run your own branded peptide program on AXIOM’s regulatory rails.

For telehealth networks, MSO groups, and franchise systems with their own brand and customer base. Custom logo on the pen, custom retail packaging, a subdomain portal at brand.axiomscript.com. The underlying device 510(K), the PCAB-accredited pharmacy network, and the audit-log infrastructure are shared with the AXIOM mainline.

Custom branding on the pen

Logo and brand colors laser-engraved or printed directly on every device.

Custom carrying case

Logo-stamped carrying cases that reinforce your brand at every touchpoint.

Custom dosing

Tailored dose increments and ranges configured to your specific formulations.

Custom instruction manual

Branded patient instructions designed with your guidelines and compliance.

Custom retail packaging

Fully branded packaging ready for pharmacy shelves or direct-to-patient delivery.

Your subdomain, your portal

Patients and clinicians log in at your subdomain, see your branding, and never see ours. The whole experience is yours.

Custom branded reusable injector pen with logo and carrying case

Frequently asked

Common questions about AXIOM peptide therapy.

Quick answers to what clinicians, pharmacies, and patients ask most about the AXIOM reusable peptide pen, the cartridges, and how the program works.

What peptides does AXIOM offer?

AXIOM cartridges are available now for:

  • NAD+: cellular energy and longevity support
  • CJC‑1295 / Ipamorelin / Sermorelin: growth hormone optimization blend
  • Pentadeca Arginate: performance and recovery

Coming soon: Sermorelin (single peptide), Thymosin Alpha‑1, BPC‑157 / TB‑500, GHK‑Cu / KPV / TB / BPC stack, Tesamorelin, MOTS‑C.

Is the AXIOM pen FDA cleared?

Yes. The AXIOM reusable peptide pen is FDA 510(K) cleared and produced in a cGMP, ISO 13485:2016, ISO 9001 certified facility. The cartridges are compounded by PCAB-accredited 503A pharmacies (Pharmacy Compounding Accreditation Board) following inspection by the National Association of Boards of Pharmacy and the Accreditation Commission for Health Care.

Where is AXIOM available?

AXIOM cartridges are available across 45 states today. Pending: Alabama, Arkansas, California, Massachusetts, South Carolina (expected within the next two quarters). The right pharmacy is selected automatically per state for every order, so clinicians don’t have to track licensing themselves.

How long does one cartridge last?

Each 3 mL cartridge provides roughly 4 to 5 weeks of therapy at the standard prescribed doses. Each cartridge holds 300 IU (300 clicks at 1 IU per click). Patients swap cartridges by hand, no tools required.

How does precision dosing work on the AXIOM pen?

The pen supports 0 to 60 IU per injection with a minimum unit dose of 0.01 mL. One click equals one IU equals 0.01 mL. Pressing force is under 5 N at 36 to 37 units and under 8 N at 74 to 80 units, designed for comfortable self-administration.

Can I white-label AXIOM for my clinic network?

Yes. AXIOM offers an end-to-end white-label program: custom branding on the pen itself, custom carrying case, custom unit dosing, custom patient instruction manual, custom retail packaging, and a branded portal at your subdomain. Same FDA-cleared device, same PCAB pharmacy network, your name on every touchpoint.

What kind of pharmacies fulfill AXIOM cartridges?

AXIOM-enabled pharmacies are licensed 503A compounding pharmacies, all PCAB accredited. PCAB accreditation requires inspection for cleanliness and sterile processes, proper ingredient sourcing, accurate dosing and formulation, and staff training and procedures. Every cartridge ships with a lot number tied back to the production batch.

How does a clinic onboard with AXIOM?

Clinics submit a partnership inquiry via the form below or sign in to the portal at app.axiomscript.com. Onboarding typically takes under a week: state-license validation, physician registration, ACH payment connection via Plaid, and TOS / privacy / BAA acceptance. After that, placing an order takes under a minute.

How is AXIOM different from buying compounded peptides at any pharmacy?

Three things. (1) The device: a reusable, FDA 510(K) cleared peptide pen rated for 3,000+ injection cycles, not a vial-and-syringe workaround. (2) The network: every cartridge ships from a PCAB-accredited 503A pharmacy licensed in the patient’s state, automatically. (3) The program: clinic ordering, pharmacy production, and corporate roll-up are all on a single audit-grade platform built for HIPAA and 21 CFR Part 11 from day one.

Get started

Bring AXIOM to your clinic, your pharmacy, or your network.

Whether you’re a clinician ready to prescribe, a 503A pharmacy ready to compound, or a network ready to launch a branded peptide program, the conversation is short. Tell us where you fit and we’ll be back in touch within the day.